Remus Pharmaceuticals shares H1 FY27 earnings call audio

Investor Communications View source PDF Explain this filing

REMUS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-3.4%Reaction day

₹844.20

prior close

₹852.00

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+2.2%-5.6% vs market

On the reaction day the stock moved 5.6 pts less than Nifty Microcap 250, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

-4.9

Sessions after the filingfrom the prior close

StockMarketvs market

Reaction day

-3.4+2.2-5.6

Next day

-0.5+3.3-3.8

-3.6pendingpending

———

15d

———

UpDownMarket · Nifty Microcap 250Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

The audio recording of Remus Pharmaceuticals' earnings call held on November 4, 2026, covering the half year ended September 30, 2026, is available on the company website. The company stated that no unpublished market-sensitive information was discussed.

Likely market impact

The filing only provides the earnings call recording, with no new financial or operating guidance. No direct change to investor estimates is expected.